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Staphylococcus aureus preferentially catabolizes glucose, generating pyruvate, which is subsequently oxidized
to acetate under aerobic growth conditions. Catabolite repression of the tricarboxylic acid (TCA) cycle results
in the accumulation of acetate. TCA cycle derepression coincides with exit from the exponential growth phase,
the onset of acetate catabolism, and the maximal expression of secreted virulence factors. These data suggest
that carbon and energy for post-exponential-phase growth and virulence factor production are derived from the
catabolism of acetate mediated by the TCA cycle. To test this hypothesis, the aconitase gene was genetically
inactivated in a human isolate of S. aureus, and the effects on physiology, morphology, virulence factor
production, virulence for mice, and stationary-phase survival were examined. TCA cycle inactivation prevented
the post-exponential growth phase catabolism of acetate, resulting in premature entry into the stationary
phase. This phenotype was accompanied by a significant reduction in the production of several virulence
factors and alteration in host-pathogen interaction. Unexpectedly, aconitase inactivation enhanced stationary-
phase survival relative to the wild-type strain. Aconitase is an iron-sulfur cluster-containing enzyme that is
highly susceptible to oxidative inactivation. We speculate that reversible loss of the iron-sulfur cluster in
wild-type organisms is a survival strategy used to circumvent oxidative stress induced during host-pathogen
interactions. Taken together, these data demonstrate the importance of the TCA cycle in the life cycle of this
medically important pathogen.
Staphylococcus aureus is a gram-positive pathogen that
causes a wide variety of diseases in humans and animals, rang-
ing from local soft-tissue infections to life-threatening septice-
mia. S. aureus causes disease by producing many extracellular
virulence factors, including several proteases, lipases, hemo-
lysins, superantigens, and cell wall-associated adherence pro-
teins. As with many pathogens, maximal expression of S. aureus
virulence factors occurs during the post-exponential phase of
growth (33). Bacteria exit from the exponential phase of
growth upon the depletion of readily catabolizable carbon
compounds and/or the accumulation of toxic compounds. Dur-
ing growth in vitro, S. aureus preferentially degrades glucose to
pyruvate (9, 18, 22, 28) by way of the pentose phosphate and
glycolytic pathways (4). The catabolic fate of pyruvate is de-
termined by the growth conditions. Under anaerobic growth
conditions, pyruvate is primarily reduced to lactic acid (22, 24),
while it is oxidized to acetate and CO2 under aerobic growth
conditions (16). The ability to oxidize acetate in the exponen-
tial phase of growth is severely impaired, and acetate accumu-
lates in the culture medium until the glucose has been depleted
(9, 18). Thus, maximal expression of virulence factors coincides
with the depletion of glucose, entry into the post-exponential
phase of growth, and the catabolism of acetate. Taken to-
gether, these data suggest that the carbon and energy needed
for post-exponential-phase growth and virulence factor pro-
duction are primarily derived from the catabolism of acetate.
Acetate in the form of acetyl-coenzyme A (CoA) can be
oxidized by the tricarboxylic acid (TCA) cycle when S. aureus
is grown in the presence of certain TCA cycle intermediates
(18). Therefore, it is reasonable to hypothesize that inactiva-
tion of the TCA cycle would detrimentally affect acetate ca-
tabolism, growth, and virulence factor production. To test this
hypothesis, aconitase (EC 4.2.1.3) was genetically inactivated
in a low-passage human isolate of S. aureus, and growth, glu-
cose-acetate catabolism, virulence factor production, and vir-
ulence for mice were characterized.
MATERIALS AND METHODS
Bacterial strains, plasmids, and materials. The strains and plasmids used in
this study are listed in Table 1. Escherichia coli strains were grown in 2 YT
broth or on 2 YT agar (34). S. aureus strains were grown in tryptic soy broth
containing 0.25% glucose (TSB) (BD Biosciences, Sparks, Md.) or on TSB
containing 1.5% agar. All antibiotics were purchased from Sigma Chemical Co.
(St. Louis, Mo.) and were used at the following concentrations: ampicillin, 100
g/ml (E. coli); erythromycin, 8 g/ml, and chloramphenicol, 7.5 g/ml (S.
aureus).
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S. aureus aconitase mutant construction. A 1-kb internal fragment (nucleo-
tides 1191 to 2195 relative to the start codon) was amplified by PCR and cloned
into the SmaI site of pBluescript II K/S() (Stratagene) to generate the plasmid
pGAS-4. The ermB cassette of pEC4 (5) was inserted into the NsiI site contained
within the acnA fragment of pGAS-4 to yield the plasmid pGAS-5. The
acnA::ermB fragment was PCR amplified and cloned into the SmaI site of the
temperature-sensitive plasmid pTS1 (19) to generate the plasmid GAS-6. The
temperature-sensitive plasmid pGAS-6 was isolated from S. aureus strain
RN4220 (32) and was introduced into strain SA564 by electroporation (35). The
transformed strain was then used to construct an aconitase mutant by the method
described by Foster (15). Putative mutants were analyzed by PCR and Southern
blotting (38) and assayed for aconitase activity.
Enzymatic-activity assays. Cell lysates of S. aureus were prepared as follows.
Aliquots (3 ml) were harvested at the appropriate times and resuspended in 1.5
ml of lysis buffer containing 90 mM Tris (pH 8.0), 100 M fluorocitrate, and 50
g of lysostaphin (Sigma)/ml. The samples were incubated at 37°C for 10 min
and passed through a French press (two times at 15,000 lb/in2). The lysate was
centrifuged for 5 min at 20,800 g and 4°C. Aconitase activity was assayed in the
resulting cell lysate by the method described by Kennedy et al. (23). One unit of
aconitase activity is defined as the amount of enzyme necessary to give a A240
min1 of 0.0033 (3). Protein concentrations were determined by the method of
Lowry et al. (26).
Measurement of citrate, acetate, glucose, lactate, and ammonia in culture
supernatants. Aliquots of bacteria (1.5 ml) were centrifuged for 5 min at 20,800
 g in a refrigerated centrifuge. The culture supernatants were adjusted to pH 8
with KOH. Citrate, acetate, glucose, lactate, and ammonia concentrations were
determined with kits purchased from R-Biopharm, Inc. (Marshall, Mich.) and
used according to the manufacturer’s directions.
Determination of stationary-phase survival. Single colonies of SA564 and
SA564-acnA::ermB were inoculated into 1-liter flasks containing 100 ml of TSB,
grown at 37°C, and aerated by shaking them at 225 rpm for up to 2 weeks.
Aliquots (200 l) were taken at 24-h intervals, and the CFU per milliliter were
determined on TSB containing 1.5% agar. Sterile deionized water was added as
needed to offset the evaporative loss of water.
Two-dimensional electrophoresis and protein identification. Procedures for
two-dimensional electrophoresis and identification of proteins by matrix-assisted
laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS)
have been described previously (6). Equivalent quantities of total protein (80 
g) were used in each two-dimensional (2-D) electrophoresis experiment.
Determination of virulence factor production. Hemolytic activity, staphyloki-
nase activity, and the presence of clumping factor were determined as described
previously (14). Lipase activity was measured with the Lipase-PS kit (Sigma).
The relative quantity of staphylococcal enterotoxin C (SEC) was determined by
enzyme-linked immunosorbent assay with a monoclonal antibody to SEC (IGEN
International, Inc., Gaithersburg, Md.). The quantity of SEC is expressed as the
amount of horseradish peroxidase-induced absorbance at 405 nm per picogram
of total protein (A405 per picogram). The total protease activity present in culture
supernatants was determined by use of the Universal Protease Substrate (Roche
Molecular Biochemicals, Indianapolis, Ind.).
Electron microscopy. Samples of staphylococci were prepared for scanning
electron microscopy as described previously (13). The prepared samples were
examined with a Hitachi S4500 field emission scanning electron microscope. The
maximum bacterial cell lengths were determined from multiple measurements (n
 40) of bacterial samples prepared from single cultures of SA564 and SA564-
acnA::ermB. Bacterial cell measurements and statistical analyses were performed
using SigmaScan Pro version 5.0 software (SPSS Science, Chicago, Ill.).
Staphylococci were prepared for transmission electron microscopy essentially
as described previously (29).
Northern blot analysis. Northern blot analyses of RNAIII, sarA, and sigB
transcripts were performed as described previously (34). The blot was probed
with [32P]dATP-labeled (RadPrime DNA-labeling kit; Gibco BRL) PCR prod-
ucts amplified from SA564 genomic DNA. The integrated density values of
bands on autoradiographs were determined with AlphaImager 2000 software
(Alpha Innotech Corp., San Leandro, Calif.).
Mouse virulence. The virulences of the S. aureus aconitase mutant and iso-
genic wild-type strains were assessed with a mouse soft-tissue infection model
(27). The bacteria were incubated for 3 h, harvested, washed once with ice-cold
phosphate-buffered saline, frozen in liquid nitrogen, and stored at 80°C. The
CFU per milliliter were determined before the bacteria were frozen and con-
firmed when the mice were inoculated. For the soft-tissue infection model, 25
outbred, immunocompetent, hairless mice (Crl::SKH1-hrBR) were inoculated
subcutaneously. The mice were weighed prior to inoculation and once a day after
inoculation until they regained their preinoculation weight. The statistical sig-
nificances of the percentage of body weight lost and the average number of days
to regain the lost body weight were assessed with Student’s t test.
All experiments involving animals were reviewed and approved by the Rocky
Mountain Laboratories Animal Care and Use Committee and complied with
animal welfare legislation and National Institutes of Health guidelines and pol-
icies.
RESULTS
S. aureus aconitase mutant growth. Insertional inactivation
of the single aconitase (acnA) gene in S. aureus strain SA564 by
allelic replacement was verified by PCR and Southern blot
analysis (Fig. 1A). Additionally, inactivation was confirmed by
assaying aconitase activity. No detectable aconitase activity
(0.1 U mg of protein1) was found in the mutant, whereas
the isogenic strain had 141.0 U mg of total protein1, confirm-
ing the presence of a single aconitase in S. aureus (Fig. 1B).
The doubling time, the length of the exponential growth phase,
and the exponential-phase acidification of the culture medium
of the acnA mutant (SA564-acnA::ermB) were equivalent to
those of the isogenic wild-type strain (Fig. 1C). These data
suggest that TCA cycle activity is not growth limiting in wild-
type S. aureus during the exponential growth phase, consistent
with previous observations that have demonstrated TCA cycle
repression (18, 40). Unexpectedly, TCA cycle inactivation
caused S. aureus to enter the stationary phase of growth pre-
maturely (Fig. 1C). This surprising result occurred in a rich
medium containing glucose and free amino acids, suggesting
an inability to catabolize available carbon sources.
We expected that the premature entry of the aconitase mu-
tant into the stationary phase of growth would result in early
entry into the death phase. To test this hypothesis, we assessed
the stationary-phase survival of SA564-acnA::ermB and
SA564. Single colonies were inoculated into TSB and grown
aerobically for up to 2 weeks, and the CFU per milliliter were
determined daily. An aconitase mutant in the phylogenetically
TABLE 1. Strains and plasmids used in this study
Plasmid or strain Relevant genotype or characteristic(s) Source orreference
pBluescript II KS() E. coli phagemid cloning vector Stratagene
pTS1 S. aureus-E. coli temperature-sensitive shuttle vector 19
pEC4 pBluescript II KS() with ermB inserted into ClaI site 5
pGAS-4 pBluescript II KS() containing an internal fragment of the acnA gene of RN6390 inserted into SmaI site This study
pGAS-5 pGAS-4 containing the ermB cassette of pEC4 inserted into the NsiI site of the acnA fragment This study
pGAS-6 The acnA::ermB PCR product from pGAS-5 inserted into the SmaI site of pTS1 This study
RN4220 Restriction-negative S. aureus 32
SA564 Recent human S. aureus isolate J. M. Musser
SA564-acnA::ermB SA564 containing an ermB insertion into acnA This study
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FIG. 1. Characteristics of the S. aureus aconitase mutant. (A) Southern blot confirmation of acnA disruption. Genomic DNA was isolated from
strains SA564 and SA564-acnA::ermB, digested with EcoRI and EcoRV (the acnA-containing fragment is 3,400 bp), and analyzed by Southern
blotting. The ermB cassette was 1,280 bp, resulting in the 4.6-kb band observed in the mutant strain. (B) Aconitase activities of strains SA564
and SA564-acnA::ermB after 6 h of growth. (C) The wild-type strain SA564 and the aconitase mutant strain SA564-acnA::ermB were grown in TSB.
At the indicated times, an aliquot was removed, appropriate dilutions were made, and the absorbance at 600 nm was measured. (D) Glucose
depletion and acetate accumulation and depletion in the culture supernatants of strain SA564 and strain SA564-acnA::ermB plotted as a function
of growth. (E) Net ammonia accumulation in the culture supernatants of strains SA564 and SA564-acnA::ermB. (F) An example of postexponential
free amino acid depletion from the culture medium. The results presented are representative of at least two independent experiments.
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related organism Bacillus subtilis fails to sporulate during pro-
longed incubation, leading to the loss of viability (11). In con-
trast, the S. aureus aconitase mutant had greatly enhanced
stationary-phase survival relative to the wild-type strain (Fig.
2). These data demonstrate that TCA cycle inactivation does
not result in a premature death phase and indicate that a fully
functioning TCA cycle is essential for normal cell lysis.
S. aureus aconitase mutant morphology. Aconitase inactiva-
tion results in morphological defects in B. subtilis (11), Strep-
tomyces viridochromogenes (36), and Streptomyces coelicolor
(43). For example, a B. subtilis aconitase mutant failed to form
a spore or an asymmetric septum (11), and S. viridochromoge-
nes fails to form a normal aerial mycelium (36). To determine
if aconitase inactivation affected S. aureus cell morphology,
bacteria from exponentially growing (3-h) and stationary-phase
(27-h) cultures of SA564 and SA564-acnA::ermB were exam-
ined by scanning electron microscopy (Fig. 3A to D). The gross
morphologies of the aconitase mutant and wild-type strains
were similar at both time points. However, the mutant and
wild-type strains differed significantly in the maximal bacterial
lengths (i.e., the longest distance across the bacterium). As
expected, there was a significant decrease in the maximal
length of wild-type strain SA564 cells during the transition
from an exponentially growing culture to a stationary-phase
culture (0.873 0.049 and 0.719 0.042 m, respectively; P	
0.0001). However, there was no significant decrease in the
maximal length of the aconitase mutant strain upon the tran-
sition from an exponentially growing culture to a stationary-
phase culture (0.806  0.079 and 0.745  0.062 m, respec-
tively; P 
 0.09). These data suggest that the premature entry
into the stationary phase observed in the aconitase mutant
incompletely blocks the size reduction of S. aureus that occurs
during normal transition into the stationary phase of growth.
The significant difference in the maximal bacterial lengths
could be the result of an alteration in cell wall thickness. To
address this possibility, we examined strains SA564 and
SA564-acnA::ermB using transmission electron microscopy
during the exponential (3-h) and stationary (27-h) phases of
growth (Fig. 3E to H). No alterations in the gross morphology
or the cell wall thickness were observed in either the exponen-
tial or stationary phase of growth.
Glucose and acetate catabolism. S. aureus preferentially de-
grades glucose during growth (9, 18, 22, 28) (Fig. 1D). The
primary pathways for the catabolism of glucose in S. aureus are
the pentose phosphate and glycolytic pathways (4). The pro-
cessing of glucose by the pentose phosphate pathway produces
intermediates for purine biosynthesis and the glycolytic path-
way intermediates fructose 6-phosphate and glyceraldehyde
3-phosphate; the last two compounds are then converted into
pyruvate by glycolysis. The catabolic fate of pyruvate is deter-
mined by the growth conditions. During aerobic growth, pyru-
vate is enzymatically oxidized to acetyl-CoA and CO2 by the
pyruvate dehydrogenase complex (16). Additionally, acetyl-
CoA can be further oxidized by the TCA cycle when grown in
the presence of certain TCA cycle intermediates (18). To de-
termine if inactivation of TCA cycle function altered the ability
of S. aureus to catabolize glucose and/or acetate, we deter-
mined the concentrations of glucose and acetate in the culture
supernatants of the wild-type and aconitase mutant strains
grown in the presence of 0.25% glucose. Glucose was rapidly
depleted from the culture media by both strains SA564 and
SA564-acnA::ermB (Fig. 1D). Additionally, both strains accu-
mulated acetate and acidified the culture media at equivalent
rates during the exponential phase of growth (Fig. 1C and D).
In contrast to a previous report (18), our data demonstrate that
wild-type S. aureus begins to catabolize acetate at the end of
the exponential phase of growth, and catabolism continues at a
nearly constant rate until the acetate is depleted. However, the
aconitase mutant strain does not catabolize acetate (Fig. 1D),
demonstrating that a fully functioning TCA cycle is essential
for acetate catabolism.
Inactivation of aconitase prevented the depletion of acetate
from the culture medium, confirming that a metabolic block
existed in the TCA cycle. A metabolic block can result in the
accumulation of citrate in the medium and interfere with nor-
mal cellular processes (11). To examine this possibility, we
measured the concentration of citric acid in the culture super-
natant. Neither SA564 nor SA564-acnA::ermB accumulated
citrate in the medium (data not shown). Additionally, the wild-
type strain used citrate as a carbon source but the mutant did
not, consistent with aconitase inactivation (data not shown).
These data indicate that SA564-acnA::ermB does not generate
excess citrate.
Amino acid catabolism. Catabolism of amino acids is usually
accompanied by ammonia production. To measure amino acid
degradation, the concentration of ammonia in the bacterial
culture supernatants and the depletion of free amino acids
were determined. The presence of glucose in the culture media
incompletely suppressed ammonia generation in both SA564
and SA564-acnA::ermB, indicating an adequate supply of car-
bon for growth (Fig. 1E). However, upon depletion of the
glucose, strain SA564 began to accumulate ammonia in the
culture supernatant and to deplete free amino acids (Arg, Leu,
Pro, and His [data not shown and Fig. 1F]), indicating that the
culture medium had become carbon limited (Fig. 1E). In con-
trast, strain SA564-acnA::ermB failed to accumulate ammonia
in the culture medium during the postexponential phase of
growth, nor did it deplete free amino acids from the culture
FIG. 2. TCA cycle inactivation enhances stationary-phase survival.
Single colonies of SA564 and SA564-acnA::ermB were inoculated into
TSB, grown at 37°C, and aerated by being shaken at 225 rpm for up to
2 weeks. At 24-h intervals, aliquots were removed and CFU per mil-
liliter were determined in quadruplicate. The data presented are av-
erages and standard deviations.
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FIG. 3. Electron micrographs of SA564 and SA564-acnA::ermB. Scanning electron micrographs (A to D) of wild-type strain SA564 (A and C)
or the aconitase mutant strain SA564-acnA::ermB (B and D) grown for either 3 (A and B) or 27 (C and D) h are shown. Transmission electron
micrographs (E to H) of strain SA564 (E and G) or strain SA564-acnA::ermB (F and H) grown for either 3 (E and F) or 27 (G and H) h are shown.
Bars, 1.5 m (A to D) and 100 nm (E to H).
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medium (Fig. 1E and F). These data indicate that a fully
functioning TCA cycle is essential for amino acid catabolism.
Proteomic analysis of S. aureus culture supernatants. To
test the effect of TCA cycle function on virulence factor pro-
duction, we examined the production of extracellular proteins
with 2-D electrophoresis of culture supernatants. Thirteen pro-
tein spots were selected for identification by peptide mass
fingerprinting (Fig. 4). Protein spots 1 to 5 and 9 to 13 were
chosen because they were absent or greatly reduced in super-
natants prepared from strain SA564-acnA::ermB compared to
those prepared from strain SA564. Protein spots 6, 7, and 8
were characterized because the intensities were predominantly
invariant between the wild-type and mutant strains in repeated
gels. All 13 protein spots were identified by MALDI-TOF MS
analysis.
Protein spots 1, 2, and 3 are glycerol ester hydrolase (geh)
(EC 3.1.1.3). The relative migration of the proteins isolated
from the culture supernatants of the wild-type strain suggests
that these three protein spots are degradation products of
mature-form variants of lipase. There was a 50% reduction in
total lipase activity in the culture supernatants of the mutant
relative to those of the wild-type parental strain (data not
shown). The presence of residual lipase activity is consistent
with the production of a second lipase (see below). Protein
spots 4 and 12 are a type C enterotoxin (SEC). The densities of
spots 4 and 12 were twofold lower in the aconitase mutant
relative to the wild-type strain. Enzyme-linked immunosorbent
assays confirmed that the relative quantity of SEC present in
the culture supernatant of the wild type (0.05 A405/pg) was
greater than in the aconitase mutant strain (0.02 A405/pg).
Protein spots 5, 9, and 13 are -toxin (hla). Analysis of the
hemolytic titers of culture supernatants confirmed that
SA564-acnA::ermB had twofold less -toxin activity than wild-
type SA564 (data not shown). Protein spots 10 and 11 are
serine protease variants. The culture supernatants were as-
sayed for total protease activity, and no significant difference
was detected.
Protein spot 6 is phospholipase C (EC 3.1.4.10). Protein
spots 7 and 8 were tentatively identified as variant forms of
lipase (EC 3.1.1.3). Based on genomic DNA sequence data
available for S. aureus strain COL (http://www.tigr.org/), there
are at least three genes that encode proteins with lipase activ-
ity. Taken together, these data indicate that TCA cycle inacti-
vation had a pleiotropic effect on virulence factor production.
Characterization of production of additional virulence fac-
tors. S. aureus secretes or has on its cell surface several viru-
lence factors that were not identified by 2-D gel analysis of the
culture supernatants. To assess the effect of aconitase inacti-
vation on the production of virulence factors not identified by
proteomic analysis, we examined the bacteria for the presence
of the fibrinogen receptor (clumping factor) and staphyloki-
nase activity and examined culture supernatants for -toxin
activity and total protease activity. The wild-type SA564 strain
clumped in the presence of fibrinogen, but the aconitase mu-
tant did not. The levels of staphylokinase and protease activity
were equivalent in the acnA mutant and the wild-type strain
(data not shown). -Toxin activity (encoded by hlb) in the
culture supernatant of SA564-acnA::ermB was four times lower
than in the wild-type strain (data not shown). Taken together,
these data demonstrate that TCA cycle inactivation detrimen-
tally affects the production of secreted virulence factors and
cell-associated adhesion factors.
Analysis of RNAIII, sarA, and sigB RNA expression. The
synthesis of many S. aureus virulence factors is regulated
through an unknown mechanism by RNAIII, part of the agr
operon. SarA indirectly regulates the expression of virulence
factors by positively affecting the expression of RNAIII (8, 31).
However, SarA can also act independently of agr to influence
expression of virulence factors, such as -toxin (7). The ex-
pression of sarA is in part regulated by B (12). To examine the
effect of TCA cycle inactivation on the level of RNAIII made
by the wild-type and the aconitase mutant strains, we per-
formed Northern blot analysis on total RNA isolated after 3 h
(exponential phase) and 12 h (stationary phase) of growth.
Significantly more RNAIII (14-fold higher) was present in the
aconitase mutant than in the wild-type strain in the stationary
phase (Fig. 5). However, the quantities of RNAIII detected in
the mutant and wild-type strains were not significantly different
in the exponential phase, consistent with our observation that
TCA cycle inactivation does not alter exponential-phase
growth.
The level of RNAIII has been shown to correlate with the
level of SarA production (8), suggesting that increased tran-
scription of sarA in the aconitase mutant was responsible for
the enhanced expression of RNAIII. To test this hypothesis,
Northern blot analysis of total RNA was done with a sarA-
specific probe. The mutant strain had significantly (10-fold)
more sarA mRNA than the wild-type strain in the exponential
and stationary phases (Fig. 5). The stationary-phase increase in
sarA mRNA coincided with an increase in RNAIII, consistent
with the possibility that increased RNAIII is due to an increase
in SarA. Interestingly, the expression of sarA was elevated in
the aconitase mutant during exponential-phase growth, sug-
gesting that TCA cycle function, or aconitase specifically, af-
fects sarA regulation.
Inactivation of the gene (sigB) encoding B increases expres-
sion of sarA (7). Therefore, the increased level of sarA mRNA
detected in the aconitase mutant could be caused by decreased
expression of sigB. However, expression of sigB in the acnA
mutant in the exponential phase of growth was not substan-
tially changed (Fig. 5). In contrast, sigB expression was dra-
matically lower in the stationary phase.
In the context of a current model of virulence gene regula-
tion in S. aureus (33), the most likely explanation for these data
is that inactivation of the TCA cycle prevents the post-expo-
nential-phase continuance of sigB expression, yielding in-
creased sarA expression and causing an increase in the expres-
sion of RNAIII. However, this model is incomplete, as it does
not explain the increased sarA expression during the exponen-
tial phase of growth.
Virulence in a mouse soft-tissue infection model. Prelimi-
nary experiments indicated that aconitase inactivation did not
significantly alter the ability of the mutant to cause disease
in mice after intraperitoneal inoculation (data not shown).
Therefore, to assess differences in gross pathology, we used a
mouse soft-tissue infection model to measure the effect of
aconitase inactivation on virulence. Mice infected with the
aconitase mutant strain lost significantly more body weight
than mice infected with the wild type (10.5%  3.5% versus
8.7%  3.1%; P 
 0.026). Similarly, mice infected with the
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mutant organism required 5.8  2.0 days to regain their pre-
inoculation body weight, whereas animals inoculated with the
wild-type strain required an average of 4  1.2 days (P 

0.0005). Animals inoculated with the wild-type strain devel-
oped a marked ulceration at the injection site by the second
day after infection, whereas animals infected with the mutant
strain did not develop the same degree of ulceration until 4 or
more days after inoculation (Fig. 6). Additionally, mice in-
FIG. 4. 2-D electrophoresis of SA564 and SA564-acnA::ermB culture supernatant proteins. Stationary-phase (12-h) culture supernatants were
isolated from bacteria grown in protein-free TSB. Isoelectric focusing conducted with a pH 3 to 10 linear separation range showed that the majority
of exoproteins had isoelectric points in the pH 6 to 10 range (data not shown). Therefore, subsequent isoelectric focusing was done with a linear
separation range from pH 6 to 11. Protein spots analyzed by MALDI-TOF MS are indicated. The results are representative of multiple experiments
using supernatant proteins from two independent isolations.
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fected with the aconitase mutant took longer to reepithelize
the ulcer site (Fig. 6). Although these data clearly indicate that
aconitase inactivation altered pathogen-host interactions, the
overall characters of the gross lesions in mice infected with the
wild-type strain and the mutant strain were similar. The most
notable difference in soft-tissue pathology between mice in-
fected with the mutant and the wild-type strains was that the
mutant-infected mice required a longer time to develop ulcers.
DISCUSSION
The existence of a TCA cycle in S. aureus was first reported
in 1937 (24). However, an S. aureus allelic-replacement mutant
in the TCA cycle had not been made prior to this study. In
spite of this, some aspects of TCA cycle function were correctly
deduced: acetate catabolism is mediated by the TCA cycle (18,
24, 39), and glucose represses TCA cycle activity (9, 18, 40).
However, our study revealed many unexpected findings caused
by TCA cycle inactivation: (i) TCA cycle inactivation com-
pletely prevents post-exponential-phase growth in a rich me-
dium, (ii) a fully functional TCA cycle is necessary for maximal
virulence factor production, (iii) TCA cycle inactivation alters
pathogen-host interaction, and (iv) the TCA cycle is essential
for entry into the death phase. These findings demonstrate the
extent to which the TCA cycle is integrated into the life cycle
of this critical human pathogen.
TCA cycle function during growth. S. aureus preferentially
utilizes glucose via glycolysis during exponential-phase growth.
The growth of bacteria with a functional TCA cycle under
aerobic conditions can result in the incorporation of acetyl-
CoA into citrate. This reaction is catalyzed by citrate synthase,
the first enzyme of the TCA cycle. In S. aureus, the activity of
citrate synthase does not increase until the bacteria enter the
post-exponential phase (G. A. Somerville, unpublished data).
Similarly, the levels of aconitase and isocitrate dehydrogenase
activities, the second and third enzymes of the cycle, also in-
crease upon entry into the post-exponential phase (Somerville,
unpublished). Hence, carbon is not entering the TCA cycle
during exponential-phase growth, and therefore, disruption of
the TCA cycle would not be expected to alter exponential-
phase growth. The observation that the wild type and the
aconitase mutant have equivalent growth rates confirmed this
hypothesis (Fig. 1C). However, upon depletion of glucose,
TCA cycle function becomes essential for acetate catabolism
FIG. 5. Northern blot analysis of RNAIII, sarA, and sigB transcrip-
tion. Total RNA was isolated from bacteria grown to exponential (3-h)
and stationary (12-h) phases; 10 g of total RNA was used per lane. To
ensure that equivalent quantities of RNA were loaded, the RNA was
visualized by ethidium bromide staining prior to transfer to a charged
nylon membrane (data not shown). Radiolabeled probes specific for
RNAIII, sarA, and sigB were used. The results presented are repre-
sentative of multiple Northern blots with independently isolated total-
RNA samples. W.T., wild type; acnA, SA564-acnA::ermB.
FIG. 6. Disease progression in mice infected subcutaneously with SA564 or SA564-acnA::ermB. Ten outbred, immunocompetent, hairless mice
(Crl::SKH1-hrBR) were inoculated subcutaneously with 3  107 CFU of SA564 or SA564-acnA::ermB. Disease progression was followed for 18
days, and representative results are shown.
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and post-exponential-phase growth (Fig. 1C and D). Surpris-
ingly, TCA cycle inactivation also prevented the post-exponen-
tial growth phase catabolism of certain amino acids (Fig. 1F).
If S. aureus withdraws TCA cycle intermediates for amino acid
biosynthesis, then the available oxaloacetate is quickly de-
pleted, thus precluding the introduction of acetyl-CoA into the
cycle. Therefore, for S. aureus to gain energy from the TCA
cycle by acetate catabolism, it must have a pool of TCA cycle
intermediates to provide C4 or C5 intermediates. These inter-
mediates can be supplied by the catabolism of amino acids, an
idea put forth previously (18). Taken together, these data dem-
onstrate that acetate and amino acid catabolism is essential for
post-exponential-phase growth under aerobic growth condi-
tions.
TCA cycle function and virulence factor production. In the
absence of a functional TCA cycle, the production of several
virulence factors was significantly reduced (Fig. 4). The sim-
plest explanation for the decreased production of virulence
factors is that the premature entry into the stationary phase
circumvents the normal post-exponential growth phase pro-
duction of virulence factors. Implicit in this hypothesis is that
the production of all virulence factors should be affected equal-
ly; however, this was not the case. We found that the produc-
tion of - and -toxins, glycerol ester hydrolase (lipase), and
SEC was decreased in the isogenic mutant (Fig. 4 and data not
shown), but production of staphylokinase, total protease, and
variant forms of lipase was unchanged. An additional explana-
tion is that an alteration in the expression of the global gene
regulator RNAIII, sarA, or sigB (Fig. 5) causes pleiotropic
effects on virulence factor synthesis. However, the exact role of
the TCA cycle in virulence factor production remains to be
elucidated.
Aconitase inactivation, virulence, and in vivo mutagenesis
screening. TCA cycle inactivation dramatically altered the life
cycle of S. aureus. Thus, it is surprising that three independent
in vivo mutagenesis screens failed to uniformly identify TCA
cycle enzymes as important in virulence (10, 25, 30). However,
a possible explanation is that each of the three studies used the
highly passaged S. aureus strain RN6390. Recently, we dem-
onstrated that S. aureus undergoes significant phenotypic and
genotypic changes during serial passage (37). Specifically, we
demonstrated that passage of S. aureus decreases TCA cycle
function by decreasing aconitase activity. Additionally, all mu-
tagenesis screens were conducted with mice, which are not
normally infected by S. aureus; thus, detecting subtle changes
in host-pathogen interactions requires greater vigilance or a
different animal model. Consistent with this, our mouse soft-
tissue infection results indicate that disruption of aconitase
significantly alters pathogen-host interaction but does not sub-
stantially decrease virulence in this animal model. The altered
pathogen-host interaction is most likely due to decreased vir-
ulence factor production, decreased growth yield, or enhanced
stationary-phase survival.
Implications for TCA cycle inactivation in vivo. Phagocytic
leukocytes use reactive oxygen species (superoxide radicals,
hydrogen peroxide, and hydroxyl radicals) to control microbial
pathogens as an important part of the innate immune response
(2). The enzymatic activity of aconitase is mediated by an
essential iron-sulfur center [4Fe-4S] that is especially suscep-
tible to inactivation by oxygen radicals (17). Oxidative loss of
the fourth Fe atom produces an enzyme that is in the [3Fe-4S]
state, resulting in reversible inactivation of aconitase and the
TCA cycle. Our data demonstrated that genetically inactivat-
ing the TCA cycle induced an unusual and unexpected pheno-
type characterized by premature entry into the stationary
phase (Fig. 1C) and enhanced survival (Fig. 2). Hence, we
speculate that reversible aconitase inactivation in wild-type S.
aureus is a survival response to oxidative stress induced during
host-pathogen interactions. This hypothesis might also explain
the delayed disease resolution in mice infected with the acon-
itase mutant strain (Fig. 6) (i.e., the mutant bacteria are better
able to survive, and thus, bacterial clearance is delayed). Al-
though speculative, it is possible that aconitase inactivation
contributes to prolonged survival within a host.
Possible role for aconitase in addition to its enzymatic func-
tion. Aconitase is a TCA cycle enzyme that converts citrate to
isocitrate via a cis-aconitate intermediate. Eukaryotic organ-
isms have mitochondrial and cytoplasmic aconitase activities
(20). The cytoplasmic aconitase activity is caused by the iron-
responsive protein-1 (IRP-1), an mRNA-binding protein that
posttranscriptionally regulates the synthesis of iron-regulated
proteins (21). Thus, cytosolic aconitase is a bifunctional pro-
tein. Recently, it has been demonstrated that aconitases from
B. subtilis and E. coli bind to elements in mRNAs in an iron-
dependent fashion (1, 41, 42). These observations established
bacterial aconitase, like eukaryotic cytosolic aconitase (IRP-1),
as a bifunctional protein. Determining if aconitase has a reg-
ulatory role in S. aureus virulence factor production is under
way.
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